BPG is committed to discovery and dissemination of knowledge
Associate Editor
Mark De Ridder graduated at the medical school of the Vrije Universiteit Brussel (VUB) with maxima cum lauda in 1998. He combined his training in Radiotherapy and Oncology with a doctoral fellowship (FWO-Vlaanderen) and defended his PhD “Hypoxic tumor cell radiosensitization through nitric oxide synthase: role of the NF-kB signalling pathway” in 2005. He was nominated professor of Oncology and Cancer Biology at the VUB in 2008 and head of the Radiotherapy department of the UZ Brussel in 2010. His translational research program is focused on stereotactic radiotherapy and colorectal cancer.